Business
US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 ‘cure’ – Sydney Morning Herald
Eli Lilly’s announcement comes one day after Johnson & Johnson said it was forced to pause a large high-profile trial of its experimental coronavirus vaccine be…
Lilly said earlier this month it was applying for emergency use authorisation (EUA) for the antibody drug, LY-CoV555, for patients with mild to moderate COVID-19 based on data from another clinical trial.
It is not uncommon to pause drug trials to investigate safety concerns, and such actions do not necessarily indicate a serious problem. Because of the urgent need for drugs and vaccines to tackle a pandemic that has claimed over 1 million lives worldwide – and the speed with which they are bei…
-
Noosa News6 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
General12 hours agoBoy dies after being trapped between rocks off NSW beach
-
Noosa News13 hours agoFarmer Fred Perry’s 30-year conservation project creates bird haven after years of ‘bashing and burning’
-
Noosa News13 hours agoDetectives continue to search for answers on Crystal Beale’s death